[at The Wall Street Journal] – Dow Rises 7.7% in September The Dow industrials fell 47.23 points, or 0.4%, to 10788.05 on the final day of September, a period in which blue chips rose 7.7%. The measure rose 10.4% in the third quarter.
Summary Box: Best September for Dow since 1939
September - 30 - 2010
[AP] – TRAILING OFF: The Dow Jones industrial average fell 47 points on Thursday, but still closed out its best September in 71 years with a gain of 7.7 percent.
Biggest Surprises This Quarter: Priceline Up 97%
September - 30 - 2010
[at CNBC] – US stocks posted their largest quarterly gain since Q3 2009, with the major averages rising north of 10 percent. Here is a look the winners and losers.
US STOCKS-Wall St slips, but logs best quarter in a year
September - 30 - 2010
[at Reuters] – * Indexes log best quarter in a year; S&P up 10.7 pct * Jobless claims fall, Q2 GDP growth reading revised up * Semiconductors shares fall, but Boeing advances
Cramer s Mad Money Recap: The Challenge of Stock Picking (Final)
September - 30 - 2010
[at TheStreet.com] – Cramer tells what he goes through to pick that stocks that provide maximum capital gains at minimal risks.
Cramer s Mad Money Recap: The Challenge of Stock Picking (Final)
September - 30 - 2010
[at TheStreet.com] – Cramer tells what he goes through to pick that stocks that provide maximum capital gains at minimal risks.
Why Advance America Only Looks Like a Steal
September - 30 - 2010
Saj Karsan submits:
Two parties can want to make a deal, but a third party (namely, the government) can prevent that deal from taking place. Such is the case for Advance America (AEA) provider of very short-term loans in Canada and the United States. At the current price, the company looks like a steal.
The company’s P/E is under 5, and while the company trades for $230 million, it has earned over $200 million in the last four years! The company has been able to generate returns on equity in the mid-to-high 20 percents, showing that it’s got an economic moat.
China-Biotics: Pictures Provide Evidence of a High Quality Business
September - 30 - 2010
Jason Nevader submits:
During my recent due-diligence trip to Shanghai, I got a chance to validate my investment thesis that China-Biotics (CHBT) is my top stock pick based on its 0.16 PEG ratio and Enterprise Value / fiscal 2011 EBITDA multiple of 1.7x.
Sean Wright did an excellent job of reporting on what was learned from reviewing the bank statements, tax filings, and speaking with the 3 distributors and 4 bulk customers on Investor Day. You can read what he wrote at: China-Biotics: What Really Happened at the Investor Day or my detailed blog. In this article, I will share other items I learned from my first hand visit at China-Biotics.
Retail Operations